FDA Inspection 806735 — University of Pittsburgh Cancer Institute Cancer Service
The FDA completed an inspection of University of Pittsburgh Cancer Institute Cancer Service on November 9, 2012 in Erie, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 9, 2012
- Fiscal Year
- 2013
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Erie, PA (United States)